High materiality8/10
Tango Therapeutics price target raised to $42 from $30 at Canaccord
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Canaccord raises Tango Therapeutics PT to $42; current price about $30.93; notable upside.
- PT $42; price $30.93; upside ~36%.
Key facts
- 01
Target: $42
- 02
Posted price: $30.93
- 03
Analyst firm: Canaccord Genuity
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.